Many Bright Ideas Technologies, Inc. operates as a life science company. The firm engages in the development and commercialization of genomic-based clinical laboratory diagnostic tests. It focuses on managing the license and rights for GeneFx Lung, prognostic genomic-based test for non-small-cell lung cancer. The company was founded on April 28, 2006 and is headquartered in Vancouver, Canada.